OM
Opaleye Management Portfolio holdings
AUM
$494M
This Quarter Return
-9.45%
1 Year Return
+68.17%
3 Year Return
+608.37%
5 Year Return
+807.76%
10 Year Return
+24,567.28%
AUM
$449M
AUM Growth
+$449M
(-21%)
Cap. Flow
-$41.6M
Cap. Flow
% of AUM
-9.26%
Top 10 Holdings %
Top 10 Hldgs %
73.91%
Holding
54
New
15
Increased
8
Reduced
14
Closed
9
Top Buys
| 1 |
SNWV
SANUWAVE Health, Inc. Common Stock
SNWV
|
$34.4M |
| 2 |
Immunome
IMNM
|
$10.2M |
| 3 |
Liquidia Corp
LQDA
|
$8.29M |
| 4 |
Anika Therapeutics
ANIK
|
$5.94M |
| 5 |
PVLA
Palvella Therapeutics, Inc. Common Stock
PVLA
|
$4.82M |
Top Sells
| 1 |
TG Therapeutics
TGTX
|
$68M |
| 2 |
Ocular Therapeutix
OCUL
|
$20.1M |
| 3 |
Trevi Therapeutics
TRVI
|
$9.58M |
| 4 |
Jasper Therapeutics
JSPR
|
$8.55M |
| 5 |
NewAmsterdam Pharma
NAMS
|
$8.35M |
Sector Composition
| 1 | Healthcare | 97.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Regenxbio
RGNX
$498M
| – | – |
-80,000
| Closed | -$618K |
|
52
UroGen Pharma
URGN
$896M
| – | – |
-220,000
| Closed | -$2.34M |
|